Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
Faricimab-svoa injection is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina in the eye that causes blurring of vision or blindness. Faricimab-svoa works by changing the amount of blood that gets to the eye.
Faricimab-svoa injection is also used in diabetic patients who have diabetic macular edema (DME). Macular edema can cause loss of vision.
This medicine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2023
Copyright © 2023 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.